- Published on
Infectious Disease - Actinomycosis
FUNDAMENTAL DESCRIPTION
A persistent, slow-progressing, purulent, tissue-destructive infection characterized by the growth of lumps and sinuses, typically affecting the head and neck, but capable of influencing other regions such as the thorax and abdomen.
EPIDEMIOLOGY
Incidence • The documented incidence in the general population is approximately 1:300,000 in the United States and around 1:100,000 in Europe. • Infection manifests across all age groups, with a peak incidence during the middle decades of life. • The male-to-female ratio is 3:1.
RISK FACTORS: • Inadequate oral hygiene, dental interventions, oral surgical procedures, and
psychological injury
• Intrauterine contraceptive devices (all varieties; heightened risk if retained for over 2 years)
• Abdominal surgery, intra-abdominal inflammatory conditions (diverticulitis, appendicitis), foreign objects
Actinomycosis has been documented in contexts of malnutrition and immunodeficiency, including HIV infection, chronic granulomatous illness, and prolonged steroid usage.
Actinomycosis has been documented in patients with infected osteoradionecrosis and bisphosphonate-related mandibular osteonecrosis.
GENERAL PREVENTION
• Maintain optimal oral hygiene, including the elimination of dental plaque.
The identification of Gupta bodies or Actinomyces-like organisms (ALOs) in Papanicolaou cervicovaginal smears may assist in averting the progression of advanced pelvic disease in women with prolonged use of intrauterine contraceptive devices and symptoms indicative of early pelvic actinomycosis, including pain, abnormal bleeding, or unusual discharge. It is advised to remove the intrauterine device and administer a 2- to 3-week regimen of antibiotics in these instances.
• Patient isolation is unnecessary.
PATHOPHYSIOLOGY
Humans serve as the natural reservoir for actinomycosis pathogens.
The organisms often develop as saprophytes in the oral cavity, primarily within dental plaque and tonsillar crypts.
• Transmission likely happens through direct touch between individuals.
• The extraction of teeth or other trauma to the oral mucosa may trigger a localized infection caused by Actinomyces species.
The germs are likely aspirated and may occasionally result in lung actinomycosis.
• The majority of abdominal actinomycosis cases start in the appendix.
• While the precise incubation period remains undetermined, diagnosis typically occurs after extended durations. While an acute variant has been identified, chronic illness constitutes the predominant majority of patients.
• The disruption of the mucosal barrier appears essential for the first onset of the illness. It subsequently disseminates contiguously and/or hematogenously. Aspiration or contiguous dissemination from the cervical region results in pulmonary involvement. Foreign bodies and/or intestinal perforation resulting from appendicitis or diverticulitis contribute to the pathological processes in abdominal and pelvic diseases.
• Depending on the specific anatomical region involved, Oral/cervicofacial, thoracic, abdominal, pelvic, central nervous system (CNS), and disseminated forms of the disease are acknowledged. Muscle and bone involvement is owing to direct extension from surrounding tissue infection or, less commonly, as a result of trauma or infection dissemination.
ETIOLOGY
• Actinomyces are microaerophilic or anaerobic, filamentous, branching, Gram-positive, non-acid-fast bacilli.
• A. israelii is the most prevalent species of Actinomyces discovered in the pus and tissues of individuals afflicted with actinomycosis.
• A. naeslundii, A. meyeri, A. odontolyticus, and Propionibacterium propionica (Arachnia propionica) have been documented as causative agents of human actinomycosis.
• A. viscosus has been identified as a significant factor to the pathogenesis of periodontal disease. • Actinomyces are commensals of the oral cavity and female vaginal system. In most instances of actinomycosis, meticulous cultures produce polymicrobial isolates, predominantly comprising anaerobic constituents of the normal oral flora. These may function as copathogens in the pathological process.
DIAGNOSTIC HISTORY
• Discomfort, vaginal secretion, and/or hemorrhage (pelvic pathology) • Cephalalgia, localized neurological manifestations
• Symptoms are contingent upon the severity of the lesions and the affected organ/system. • Potential manifestations include pain, low-grade fever, and weight loss.
• Trismus (oral/cervicofacial condition) • Chest discomfort, cough (productive or non-productive), progressively worsening shortness of breath (thoracic condition) • Abdominal pain, alteration in bowel habits (abdominal condition)
PHYSICAL EXAM
The characteristic feature of the disease is the development of space-occupying lesions of diverse sizes, exhibiting variable levels of suppuration and/or fibrosis.
– Infiltration into neighboring tissues may transpire, along with outflow to nearby cavities or the skin through sinus development. Sinus conditions may be self-limiting and recurring pus typically contains yellowish "sulfur granules," observable both macroscopically and microscopically.
• Cervicofacial/oral pathology – The perimandibular area is predominantly affected; however, all regions of the head, neck, and oral cavity may be implicated, encompassing soft tissues, bones, salivary glands, thyroid, eyes (postoperative canaliculitis and endophthalmitis), and ears (chronic, myringotomy-resistant otitis media).
– The superficial skin may exhibit a purple, red, or bluish hue. • Thoracic disease – Arises from aspiration or, less commonly, contiguous spread from the cervical region. Indicators suggest a space-occupying lesion and/or pneumonitis, with pleural involvement (thickening, effusion, empyema) observed in over 50% of patients.
– The existence of several cavities and the engagement of the chest wall (including soft tissues and bones with sinus development) corroborate the diagnosis.
Mediastinal involvement, primarily affecting heart tissues, and spinal involvement may occur.
• Abdominal pathology – Symptoms include the presence of a firm or hard mass lesion, typically located in the right iliac fossa, sometimes subsequent to ruptured appendicitis.
- Disease of the left iliac fossa is a consequence of diverticulitis.
Perirectal or perianal illness manifests as chronic recurrent abscesses and the establishment of sinuses or fistulas in the pertinent area are noted. Peritonitis is uncommon.
• Pelvic disease – Manifestations include pelvic tumors and abscesses of variable extent, or it may be identified as frozen pelvis, attributable to the disease's insidious progression. • Central Nervous System disease – Focal neurological deficits and/or indicators of persistent meningitis.
DIAGNOSTIC TESTS AND INTERPRETATION Laboratory
• A significant level of suspicion arises when space-occupying lesions are associated with pus-draining sinus development and involvement of soft tissue or bone.
• Examine the bandage concealing a draining sinus for sulfur granules. • Collect the specimen prior to commencing any antimicrobial treatment.
Preliminary laboratory examinations
• Identification of filamentous, Gram-positive, non-acid-fast organisms in sulfur granules (slide examination) or in specimens taken from a typically sterile site (not in sputum, bronchial washings, or vaginal secretions
A Gram stain of the specimen exhibits more sensitivity than culturing.
• Swab cultures are not advised.
Anaerobic processing of specimens is essential.
Direct immunofluorescence employing specific antisera targeting actinomycosis drugs exhibits good specificity and sensitivity. It has mostly been utilized in the detection and prevention of diseases associated with intrauterine devices.
Imaging: Preliminary Strategy
CT and MRI are useful in delineating the disease's extent and its interaction with neighboring tissues (2, 3).
The open bronchus sign, characterized by the presence of an aerobronchogram within a mass lesion, strongly indicates lung illness.
• A serrated appearance and total involvement of bones are indicative of bone disease.
• The typical presentation of CNS disease consists of single (actinomycetoma) or several round or irregular multiloculated brain lesions, accompanied by edema and areas of low attenuation.
Pathological
Observations
Detection of macroscopic or microscopic "sulfur granules" in pus and/or tissue samples (excluding tonsils), acquired during fine-needle aspiration or biopsy. Tissue Gram and Giemsa stains will identify the organisms located in the granule's periphery.
Differential Diagnosis: Malignant Neoplasms Nocardiosis, Botryomycosis, Tuberculosis, Histoplasmosis, Blastomycosis, Cryptococcosis
THERAPEUTIC PHARMACEUTICAL
Initial Line
• Administer Penicillin G at a dosage of 10–24 million units per day intravenously (in divided doses every 4–6 hours) for a duration of 2–6 weeks, thereafter transitioning to Penicillin V at 2–4 grams per day orally for 6–12 months, or • Administer Ampicillin at a dosage of 50 mg/kg per day intravenously for 2–6 weeks, followed by Amoxicillin at 1.5 grams per day orally for 6–12 months
The duration of treatment is contingent upon the severity of the disease and the clinical response. Benign instances of cervicofacial illness may be managed solely with oral antibiotics.
Second Line • Tetracycline (minocycline) • Erythromycin (alternative for patients with allergies or during pregnancy) • Clindamycin SURGERY/OTHER PROCEDURES
Antibiotic therapy may require adjunctive treatment with surgical procedures including abscess drainage, fibrotic tissue excision, and marsupialization of persistent sinus tracts.
CONTINUED MANAGEMENT SUBSEQUENT SUGGESTIONS
• Highlight the necessity for adherence to long-term pharmacotherapy. • Monitor for signs of medication toxicity.
OUTLOOK
Typically, there is an outstanding response to antibiotics, with no resistance shown in Actinomyces (5). In the event of failure, there is a significant likelihood of an undrained abscess or a resistant bacterial copathogen.
COMPLICATIONS
• Disseminated actinomycosis • Bowel obstruction resulting from severe abdominal/pelvic actinomycosis
FUNDAMENTAL DESCRIPTION
A persistent, slow-progressing, purulent, tissue-destructive infection characterized by the growth of lumps and sinuses, typically affecting the head and neck, but capable of influencing other regions such as the thorax and abdomen.
EPIDEMIOLOGY
Incidence • The documented incidence in the general population is approximately 1:300,000 in the United States and around 1:100,000 in Europe. • Infection manifests across all age groups, with a peak incidence during the middle decades of life. • The male-to-female ratio is 3:1.
RISK FACTORS: • Inadequate oral hygiene, dental interventions, oral surgical procedures, and
psychological injury
• Intrauterine contraceptive devices (all varieties; heightened risk if retained for over 2 years)
• Abdominal surgery, intra-abdominal inflammatory conditions (diverticulitis, appendicitis), foreign objects
Actinomycosis has been documented in contexts of malnutrition and immunodeficiency, including HIV infection, chronic granulomatous illness, and prolonged steroid usage.
Actinomycosis has been documented in patients with infected osteoradionecrosis and bisphosphonate-related mandibular osteonecrosis.
GENERAL PREVENTION
• Maintain optimal oral hygiene, including the elimination of dental plaque.
The identification of Gupta bodies or Actinomyces-like organisms (ALOs) in Papanicolaou cervicovaginal smears may assist in averting the progression of advanced pelvic disease in women with prolonged use of intrauterine contraceptive devices and symptoms indicative of early pelvic actinomycosis, including pain, abnormal bleeding, or unusual discharge. It is advised to remove the intrauterine device and administer a 2- to 3-week regimen of antibiotics in these instances.
• Patient isolation is unnecessary.
PATHOPHYSIOLOGY
Humans serve as the natural reservoir for actinomycosis pathogens.
The organisms often develop as saprophytes in the oral cavity, primarily within dental plaque and tonsillar crypts.
• Transmission likely happens through direct touch between individuals.
• The extraction of teeth or other trauma to the oral mucosa may trigger a localized infection caused by Actinomyces species.
The germs are likely aspirated and may occasionally result in lung actinomycosis.
• The majority of abdominal actinomycosis cases start in the appendix.
• While the precise incubation period remains undetermined, diagnosis typically occurs after extended durations. While an acute variant has been identified, chronic illness constitutes the predominant majority of patients.
• The disruption of the mucosal barrier appears essential for the first onset of the illness. It subsequently disseminates contiguously and/or hematogenously. Aspiration or contiguous dissemination from the cervical region results in pulmonary involvement. Foreign bodies and/or intestinal perforation resulting from appendicitis or diverticulitis contribute to the pathological processes in abdominal and pelvic diseases.
• Depending on the specific anatomical region involved, Oral/cervicofacial, thoracic, abdominal, pelvic, central nervous system (CNS), and disseminated forms of the disease are acknowledged. Muscle and bone involvement is owing to direct extension from surrounding tissue infection or, less commonly, as a result of trauma or infection dissemination.
ETIOLOGY
• Actinomyces are microaerophilic or anaerobic, filamentous, branching, Gram-positive, non-acid-fast bacilli.
• A. israelii is the most prevalent species of Actinomyces discovered in the pus and tissues of individuals afflicted with actinomycosis.
• A. naeslundii, A. meyeri, A. odontolyticus, and Propionibacterium propionica (Arachnia propionica) have been documented as causative agents of human actinomycosis.
• A. viscosus has been identified as a significant factor to the pathogenesis of periodontal disease. • Actinomyces are commensals of the oral cavity and female vaginal system. In most instances of actinomycosis, meticulous cultures produce polymicrobial isolates, predominantly comprising anaerobic constituents of the normal oral flora. These may function as copathogens in the pathological process.
DIAGNOSTIC HISTORY
• Discomfort, vaginal secretion, and/or hemorrhage (pelvic pathology) • Cephalalgia, localized neurological manifestations
• Symptoms are contingent upon the severity of the lesions and the affected organ/system. • Potential manifestations include pain, low-grade fever, and weight loss.
• Trismus (oral/cervicofacial condition) • Chest discomfort, cough (productive or non-productive), progressively worsening shortness of breath (thoracic condition) • Abdominal pain, alteration in bowel habits (abdominal condition)
PHYSICAL EXAM
The characteristic feature of the disease is the development of space-occupying lesions of diverse sizes, exhibiting variable levels of suppuration and/or fibrosis.
– Infiltration into neighboring tissues may transpire, along with outflow to nearby cavities or the skin through sinus development. Sinus conditions may be self-limiting and recurring pus typically contains yellowish "sulfur granules," observable both macroscopically and microscopically.
• Cervicofacial/oral pathology – The perimandibular area is predominantly affected; however, all regions of the head, neck, and oral cavity may be implicated, encompassing soft tissues, bones, salivary glands, thyroid, eyes (postoperative canaliculitis and endophthalmitis), and ears (chronic, myringotomy-resistant otitis media).
– The superficial skin may exhibit a purple, red, or bluish hue. • Thoracic disease – Arises from aspiration or, less commonly, contiguous spread from the cervical region. Indicators suggest a space-occupying lesion and/or pneumonitis, with pleural involvement (thickening, effusion, empyema) observed in over 50% of patients.
– The existence of several cavities and the engagement of the chest wall (including soft tissues and bones with sinus development) corroborate the diagnosis.
Mediastinal involvement, primarily affecting heart tissues, and spinal involvement may occur.
• Abdominal pathology – Symptoms include the presence of a firm or hard mass lesion, typically located in the right iliac fossa, sometimes subsequent to ruptured appendicitis.
- Disease of the left iliac fossa is a consequence of diverticulitis.
Perirectal or perianal illness manifests as chronic recurrent abscesses and the establishment of sinuses or fistulas in the pertinent area are noted. Peritonitis is uncommon.
• Pelvic disease – Manifestations include pelvic tumors and abscesses of variable extent, or it may be identified as frozen pelvis, attributable to the disease's insidious progression. • Central Nervous System disease – Focal neurological deficits and/or indicators of persistent meningitis.
DIAGNOSTIC TESTS AND INTERPRETATION Laboratory
• A significant level of suspicion arises when space-occupying lesions are associated with pus-draining sinus development and involvement of soft tissue or bone.
• Examine the bandage concealing a draining sinus for sulfur granules. • Collect the specimen prior to commencing any antimicrobial treatment.
Preliminary laboratory examinations
• Identification of filamentous, Gram-positive, non-acid-fast organisms in sulfur granules (slide examination) or in specimens taken from a typically sterile site (not in sputum, bronchial washings, or vaginal secretions
A Gram stain of the specimen exhibits more sensitivity than culturing.
• Swab cultures are not advised.
Anaerobic processing of specimens is essential.
Direct immunofluorescence employing specific antisera targeting actinomycosis drugs exhibits good specificity and sensitivity. It has mostly been utilized in the detection and prevention of diseases associated with intrauterine devices.
Imaging: Preliminary Strategy
CT and MRI are useful in delineating the disease's extent and its interaction with neighboring tissues (2, 3).
The open bronchus sign, characterized by the presence of an aerobronchogram within a mass lesion, strongly indicates lung illness.
• A serrated appearance and total involvement of bones are indicative of bone disease.
• The typical presentation of CNS disease consists of single (actinomycetoma) or several round or irregular multiloculated brain lesions, accompanied by edema and areas of low attenuation.
Pathological
Observations
Detection of macroscopic or microscopic "sulfur granules" in pus and/or tissue samples (excluding tonsils), acquired during fine-needle aspiration or biopsy. Tissue Gram and Giemsa stains will identify the organisms located in the granule's periphery.
Differential Diagnosis: Malignant Neoplasms Nocardiosis, Botryomycosis, Tuberculosis, Histoplasmosis, Blastomycosis, Cryptococcosis
THERAPEUTIC PHARMACEUTICAL
Initial Line
• Administer Penicillin G at a dosage of 10–24 million units per day intravenously (in divided doses every 4–6 hours) for a duration of 2–6 weeks, thereafter transitioning to Penicillin V at 2–4 grams per day orally for 6–12 months, or • Administer Ampicillin at a dosage of 50 mg/kg per day intravenously for 2–6 weeks, followed by Amoxicillin at 1.5 grams per day orally for 6–12 months
The duration of treatment is contingent upon the severity of the disease and the clinical response. Benign instances of cervicofacial illness may be managed solely with oral antibiotics.
Second Line • Tetracycline (minocycline) • Erythromycin (alternative for patients with allergies or during pregnancy) • Clindamycin SURGERY/OTHER PROCEDURES
Antibiotic therapy may require adjunctive treatment with surgical procedures including abscess drainage, fibrotic tissue excision, and marsupialization of persistent sinus tracts.
CONTINUED MANAGEMENT SUBSEQUENT SUGGESTIONS
• Highlight the necessity for adherence to long-term pharmacotherapy. • Monitor for signs of medication toxicity.
OUTLOOK
Typically, there is an outstanding response to antibiotics, with no resistance shown in Actinomyces (5). In the event of failure, there is a significant likelihood of an undrained abscess or a resistant bacterial copathogen.
COMPLICATIONS
• Disseminated actinomycosis • Bowel obstruction resulting from severe abdominal/pelvic actinomycosis
0 Comments
